Botanix receives additional patent allowance for Sofdra®
The patent is expected to add to existing patent protections against unauthorised commercial manufacturing of Sofdra's drug substance into May 2040 Botanix Pharmaceuticals (ASX:BOT) PHOENIX, AZ, UNITED STATES, July 12, 2026 /EINPresswire.com/ -- …